Ermophilane sesquiterpenoids as HIV intergrase inhibitors
AssigneeMerck & Co., Inc.
InventorsRussell B. Lingham, Jon David Polishook, Ali Shafiee, Keith C. Silverman, Sheo Bux Singh, Deborah L. Zink
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck & Co., Inc.
InventorsRussell B. Lingham, Jon David Polishook, Ali Shafiee, Keith C. Silverman, Sheo Bux Singh, Deborah L. Zink
Estimating the term…
Natural products such as certain ermophilane sesquiterpenoids and derivatives thereof are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. The fungal culture MF6254, Xylaria sp. (ATCC 74397) is also described and disclosed.
A compound of the formula ##STR3## wherein X is selected from:
A compound of molecular formula C.sub.25 H.sub.34 O.sub.6 and having the following properties:
Dependencies are inferred from the claim text.